Living vs. deceased donor liver transplantation for hepatocellular carcinoma: A systematic review and meta-analysis

Clinical Transplantation

Volumn 27, Issue 1, 2013, Pages 140-147

  Grant, Robert C ^a   Sandhu, Lakhbir ^a   Dixon, Peter R ^a   Greig, Paul D ^a   Grant, David R ^a   Mcgilvray, Ian D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Meta analysis

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID;

ARTICLE; CADAVER DONOR; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; GRAFT REJECTION; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFORMATION RETRIEVAL; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; META ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; SYSTEMATIC REVIEW; TRANSARTERIAL CHEMOEMBOLIZATION;

CADAVER; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; META-ANALYSIS AS TOPIC; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE;

EID: 84873095086     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12031     Document Type: Article

References (35)

1. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009: 27: 1485.
2. Colella G, Bottelli R, De Carlis L et al. Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization. Transpl Int 1998: 11(Suppl 1): S193.
3. Hwang S, Lee SG, Joh JW, Suh KS, Kim DG. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transpl 2005: 11: 1265.
4. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003: 362: 1907.
5. Klein AS, Messersmith EE, Ratner LE, Kochik R, Baliga PK, Ojo AO. Organ donation and utilization in the United States, 1999-2008 . Am J Transplant 2010: 10(4 Pt 2): 973.
6. Bhangui P, Vibert E, Majno P et al. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation. Hepatology 2011: 53: 1570.
7. Picardo A, Karpoff HM, Ng B, Lee J, Brennan MF, Fong Y. Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery 1998: 124: 57.
8. Shi JH, Huitfeldt HS, Suo ZH, Line PD. Growth of hepatocellular carcinoma in the regenerating liver. Liver Transpl 2011: 17: 866.
9. Fisher RA, Kulik LM, Freise CE et al. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 2007: 7: 1601.
10. Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 2007: 94: 78.
11. Vakili K, Pomposelli JJ, Cheah YL et al. Living donor liver transplantation for hepatocellular carcinoma: increased recurrence but improved survival. Liver Transpl 2009: 15: 1861.
12. Allam N, Khalaf H, Fagih M, Al-Sebayel M. Liver transplant for hepatocellular carcinoma: experience in a Saudi population. Exp Clin Transplant 2008: 6: 14.
13. Chan SC, Fan ST, Lo CM et al. A decade of right liver adult-to-adult living donor liver transplantation: the recipient mid-term outcomes. Ann Surg 2008: 248: 411.
14. Di Sandro S, Slim AO, Giacomoni A et al. Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation. Transplant Proc 2009: 41: 1283.
15. Gondolesi GE, Roayaie S, Munoz L et al. Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg 2004: 239: 142.
16. Karakayali H, Moray G, Sozen H, Dalgic A, Emiroglu R, Haberal M. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma. Transplant Proc 2006: 38: 575.
17. Li C, Wen TF, Yan LN et al. Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation. Hepatobiliary Pancreat Dis Int 2010: 9: 366.
18. Roayaie S, Schwartz JD, Sung MW et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 2004: 10: 534.
19. Sotiropoulos GC, Lang H, Nadalin S et al. Liver transplantation for hepatocellular carcinoma: University Hospital Essen experience and metaanalysis of prognostic factors. J Am Coll Surg 2007: 205: 661.
20. Sint Nicolaas J, de Jonge V, Steyerberg EW, Kuipers EJ, van Leerdam ME, Veldhuyzen-van Zanten SJ. Risk of colorectal carcinoma in post-liver transplant patients: a systematic review and meta-analysis. Am J Transplant 2010: 10: 868.
21. Cohen J. Weighted kappa: nominal scale agreement provision for scaled disagreement or partial credit. Psychol Bull 1968: 70: 213.
22. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007: 8: 16.
23. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986: 7: 177.
24. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002: 21: 1539.
25. Egger M, Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997: 315: 629.
26. Viechtbauer W. J Stat Softw, 2010: 36: 1.
27. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2009.
28. Azzam AZ, Hegab B, Khalaf H et al. Liver transplantation in patients with hepatocellular carcinoma: a single-center experience. Exp Clin Transplant 2011: 9: 323.
29. Berg C, Merion R, Shearon T et al. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology 2011: 54: 1313.
30. Sandhu L, Sandroussi C, Guba M et al. Live donor versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence. Liver Transpl 2012: 18: 315.
31. Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010: 15(Suppl 4): 5.
32. Higgins JPT, Green S, Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions. Chichester, West Sussex; Hoboken NJ: Wiley-Blackwell, 2008: xxi.
33. Vandenbroucke JP, von Elm E, Altman DG et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Ann Intern Med 2007: 147: W163.
34. Bo WT, Yan LN. The difference and the transition of indication for adult living donor liver transplantation between the West and the East. Transplant proc 2008: 40: 3507.
35. Concejero AM, Chen CL. Ethical perspectives on living donor organ transplantation in Asia. Liver Transpl 2009: 15: 1658.